Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| cbdMD, Inc.YCBD · Entity 8230 | Director · CEO and CFO | November 28, 2025 | December 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
cbdMD, Inc.
Report date November 28, 2025 · Filed December 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 513,722 |
Reported balance
After 2025-11-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-11-28 · Grant · Acquired 445,000 · Balance 513,722 F1: The shares of restricted stock were granted pursuant to the Issuer's 2025 Equity Compensation Plan. The vesting and issuance of the shares is subject to shareholder approval. F2: The amount beneficially owned will not reconcile to the prior Form 4 due to a scriveners error. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of restricted stock were granted pursuant to the Issuer's 2025 Equity Compensation Plan. The vesting and issuance of the shares is subject to shareholder approval.
F2: The amount beneficially owned will not reconcile to the prior Form 4 due to a scriveners error.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 28, 2025 Filed Dec 2, 2025 23:29 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon Stock | 445,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-036688 · rdgdoc.xml · nonDerivative · entry 1 Kennedy Thomas Ronan · CIK 0001826452 · Director · CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 513,722 F1 · security: The shares of restricted stock were granted pursuant to the Issuer's 2025 Equity Compensation Plan. The vesting and issuance of the shares is subject to shareholder approval. F1 · price: The shares of restricted stock were granted pursuant to the Issuer's 2025 Equity Compensation Plan. The vesting and issuance of the shares is subject to shareholder approval. F2 · balance_after: The amount beneficially owned will not reconcile to the prior Form 4 due to a scriveners error. Read SEC document |
| May 06, 2025 Filed May 8, 2025 20:13 UTC | cbdMD, Inc. YCBD · Entity 8230 | Conversion8% Series A Cumulative Convertible Preferred Stock · Derivative | 41,765 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-015501 · rdgdoc.xml · derivative · entry 2 Kennedy Thomas Ronan · CIK 0001826452 · Director · CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 67,869 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") automatically converted into shares of common stock without any action on the part of the Reporting Person. The automatic conversion converts each share of the Preferred Stock into thirteen shares of the Company's common stock on May 6, 2025 at 4:01 p.m. Eastern Time. F2 · derivative.exercise_price: The price gives effect to the one-for-8 reverse stock split of the Company's issued and outstanding shares of common stock, effective May 6, 2025 at 4:02 p.m. Eastern Time. F3 · price: Open market purchases. F1 · derivative.exercise_date: The 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") automatically converted into shares of common stock without any action on the part of the Reporting Person. The automatic conversion converts each share of the Preferred Stock into thirteen shares of the Company's common stock on May 6, 2025 at 4:01 p.m. Eastern Time. F1 · derivative.expiration_date: The 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") automatically converted into shares of common stock without any action on the part of the Reporting Person. The automatic conversion converts each share of the Preferred Stock into thirteen shares of the Company's common stock on May 6, 2025 at 4:01 p.m. Eastern Time. Read SEC document |
| May 06, 2025 Filed May 8, 2025 20:13 UTC | cbdMD, Inc. YCBD · Entity 8230 | ConversionCommon Stock | 67,869 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-015501 · rdgdoc.xml · nonDerivative · entry 1 Kennedy Thomas Ronan · CIK 0001826452 · Director · CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") automatically converted into shares of common stock without any action on the part of the Reporting Person. The automatic conversion converts each share of the Preferred Stock into thirteen shares of the Company's common stock on May 6, 2025 at 4:01 p.m. Eastern Time. F2 · price: The price gives effect to the one-for-8 reverse stock split of the Company's issued and outstanding shares of common stock, effective May 6, 2025 at 4:02 p.m. Eastern Time. Read SEC document |
| September 26, 2024 Filed Sep 30, 2024 15:17 UTC | cbdMD, Inc. YCBD · Entity 8230 | Purchase8% Series A Cumulative Convertible Preferred Stock · Derivative | 1,000 | $0.55 Strike: $270.00 | $550.00 |
DisclosureSEC source: 0001437749-24-030227 · rdgdoc.xml · derivative · entry 1 Kennedy Thomas Ronan · CIK 0001826452 · CEO and CFO 10b5-1 filing: No plan indicated Ownership: Indirect · By CRED Trust Disclosed balance after: 41,765 Underlying: Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_date: The Preferred Stock has no maturity and remains outstanding unless a holder chooses to convert it into common stock, the Issuer elects to automatically convert it into shares of its common stock upon a "Market Trigger", as defined in the Issuer's Certificate of Designations, Rights and Preferences of the Preferred Stock filed on October 11, 2019 (the "Designation"), the Issuer elects to redeem it, or a Change of Control, occurs resulting in a mandatory redemption. The Issuer may elect to convert the Preferred Stock into shares of common stock if the closing price of the common stock has exceeded $371.25 for at least 20 out of 30 consecutive trading days ending within 5 trading days prior to the notice of automatic conversion. The Issuer may redeem the Preferred Stock at $10 per share, plus all accrued and unpaid dividends. Upon the occurrence of a Change of Control the Issuer will redeem all of the shares of Preferred Stock at $11 per share, plus any accrued but unpaid dividends. F1 · derivative.expiration_date: The Preferred Stock has no maturity and remains outstanding unless a holder chooses to convert it into common stock, the Issuer elects to automatically convert it into shares of its common stock upon a "Market Trigger", as defined in the Issuer's Certificate of Designations, Rights and Preferences of the Preferred Stock filed on October 11, 2019 (the "Designation"), the Issuer elects to redeem it, or a Change of Control, occurs resulting in a mandatory redemption. The Issuer may elect to convert the Preferred Stock into shares of common stock if the closing price of the common stock has exceeded $371.25 for at least 20 out of 30 consecutive trading days ending within 5 trading days prior to the notice of automatic conversion. The Issuer may redeem the Preferred Stock at $10 per share, plus all accrued and unpaid dividends. Upon the occurrence of a Change of Control the Issuer will redeem all of the shares of Preferred Stock at $11 per share, plus any accrued but unpaid dividends. F2 · ownership.nature: Represents shares of common stock held by CRED Trust for which the Reporting Person is the trustee and holds voting and dispositive control. Read SEC document |
| September 23, 2024 Filed Sep 26, 2024 00:28 UTC | cbdMD, Inc. YCBD · Entity 8230 | Purchase8% Series A Cumulative Convertible Preferred Stock · Derivative | 38,465 | $0.60 Strike: $270.00 | $23,052.07 |
DisclosureSEC source: 0001437749-24-030008 · rdgdoc.xml · derivative · entry 1 Kennedy Thomas Ronan · CIK 0001826452 · CEO and CFO 10b5-1 filing: No plan indicated Ownership: Indirect · By CRED Trust Disclosed balance after: 40,765 Underlying: Common Stock · 143 shares Expires not disclosed F1 · derivative.exercise_date: The Preferred Stock has no maturity and remains outstanding unless a holder chooses to convert it into common stock, the Issuer elects to automatically convert it into shares of its common stock upon a "Market Trigger", as defined in the Issuer's Certificate of Designations, Rights and Preferences of the Preferred Stock filed on October 11, 2019 (the "Designation"), the Issuer elects to redeem it, or a Change of Control, occurs resulting in a mandatory redemption. The Issuer may elect to convert the Preferred Stock into shares of common stock if the closing price of the common stock has exceeded $371.25 for at least 20 out of 30 consecutive trading days ending within 5 trading days prior to the notice of automatic conversion. The Issuer may redeem the Preferred Stock at $10 per share, plus all accrued and unpaid dividends. Upon the occurrence of a Change of Control the Issuer will redeem all of the shares of Preferred Stock at $11 per share, plus any accrued but unpaid dividends. F1 · derivative.expiration_date: The Preferred Stock has no maturity and remains outstanding unless a holder chooses to convert it into common stock, the Issuer elects to automatically convert it into shares of its common stock upon a "Market Trigger", as defined in the Issuer's Certificate of Designations, Rights and Preferences of the Preferred Stock filed on October 11, 2019 (the "Designation"), the Issuer elects to redeem it, or a Change of Control, occurs resulting in a mandatory redemption. The Issuer may elect to convert the Preferred Stock into shares of common stock if the closing price of the common stock has exceeded $371.25 for at least 20 out of 30 consecutive trading days ending within 5 trading days prior to the notice of automatic conversion. The Issuer may redeem the Preferred Stock at $10 per share, plus all accrued and unpaid dividends. Upon the occurrence of a Change of Control the Issuer will redeem all of the shares of Preferred Stock at $11 per share, plus any accrued but unpaid dividends. F2 · ownership.nature: Represents shares of common stock held by CRED Trust for which the Reporting Person is the trustee and holds voting and dispositive control. Read SEC document |
| May 03, 2023 Filed May 5, 2023 19:31 UTC | cbdMD, Inc. YCBD · Entity 8230 | PurchaseCommon Stock | 5,000 | $2.10 | $10,500.00 |
DisclosureSEC source: 0001437749-23-012787 · rdgdoc.xml · nonDerivative · entry 1 Kennedy Thomas Ronan · CIK 0001826452 · Interim CEO and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,462 F1 · shares: The Reporting Person purchased $10,500 worth of common stock under an Issuer registered public offering of its common stock. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 18:09 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock Options · Derivative | 75,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001654954-21-010812 · section16.xml · derivative · entry 4 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2026-10-01 F5 · security: The stock options were granted under the 2015 Equity Compensation Plan pursuant to the terms of the Executive Employment Agreement dated October 1, 2021, by and between the Issuer and the Reporting Person. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The stock options vest on October 1, 2022, subject to continued employment on the applicable vesting date. F6 · price: Not applicable. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 18:09 UTC | cbdMD, Inc. YCBD · Entity 8230 | Exercise / conversionRestricted Stock Unites · Derivative | 16,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-010812 · section16.xml · derivative · entry 3 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The restricted stock units were granted on October 1, 2021 and vest on October 1, 2022. F4 · derivative.expiration_date: The restricted stock units were granted on October 1, 2021 and vest on October 1, 2022. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 18:09 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-010812 · section16.xml · nonDerivative · entry 2 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,067 F2 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units shall vest on January 1, 2022. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2015 Equity Compensation Plan pursuant to the terms of the Executive Employment Agreement dated October 1, 2021, by and between the Issuer and the Reporting Person. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 18:09 UTC | cbdMD, Inc. YCBD · Entity 8230 | Exercise / conversionCommon Stock | 16,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-21-010812 · section16.xml · nonDerivative · entry 1 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares of common stock to be issued upon the vesting of restricted stock units which vest on October 1, 2021. Read SEC document |
| August 24, 2021 Filed Aug 25, 2021 14:15 UTC | cbdMD, Inc. YCBD · Entity 8230 | Purchase8% Series A Cumulative Convertible Preferred Stock · Derivative | 2,300 | $6.52 Strike: $6.00 | $15,005.20 |
DisclosureSEC source: 0001654954-21-009413 · section16.xml · derivative · entry 2 Kennedy Thomas Ronan · CIK 0001826452 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300 Underlying: Common Stock · 3,834 shares Expires not disclosed F1 · derivative.exercise_date: The Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") has no stated maturity and will remain outstanding indefinitely unless a holder chooses to convert the Preferred Stock into shares of the Issuer's common stock at any time, the Issuer elects to automatically convert it into shares of its common stock upon a "Market Trigger", as defined in the Issuer's Certificate of Designations, Rights and Preferences of the 8% Series A Cumulative Convertible Preferred Stock filed on October 11, 2019 (the "Designation"), on or after October 16, 2023 the Issuer elects to redeem it, or a Change of Control, (as defined in the Designation) occurs resulting in a mandatory redemption. The Issuer may elect to automatically convert some or all of the Preferred Stock into shares of its common stock if the closing price of the common stock has exceeded $8.25 (137.5% of the Conversion Price) for at least 20 out of 30 consecutive trading days ending within five trading days prior to the notice of automatic conversion. The Preferred Stock will not be redeemable before October 16, 2023 except as described below upon the occurrence of a Change of Control. Commencing on October 16, 2023, the Issuer may redeem, at its option, the Preferred Stock, in whole or in part, at a cash redemption price of $10.00 per share, plus all accrued and unpaid dividends to, but not including, the redemption date. Upon the occurrence of a Change of Control the Issuer is required to redeem any or all of the shares of Series A Convertible Preferred Stock at a redemption price of $11.00 per share, plus any accrued but unpaid dividends to, but excluding, the redemption date. F1 · derivative.expiration_date: The Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") has no stated maturity and will remain outstanding indefinitely unless a holder chooses to convert the Preferred Stock into shares of the Issuer's common stock at any time, the Issuer elects to automatically convert it into shares of its common stock upon a "Market Trigger", as defined in the Issuer's Certificate of Designations, Rights and Preferences of the 8% Series A Cumulative Convertible Preferred Stock filed on October 11, 2019 (the "Designation"), on or after October 16, 2023 the Issuer elects to redeem it, or a Change of Control, (as defined in the Designation) occurs resulting in a mandatory redemption. The Issuer may elect to automatically convert some or all of the Preferred Stock into shares of its common stock if the closing price of the common stock has exceeded $8.25 (137.5% of the Conversion Price) for at least 20 out of 30 consecutive trading days ending within five trading days prior to the notice of automatic conversion. The Preferred Stock will not be redeemable before October 16, 2023 except as described below upon the occurrence of a Change of Control. Commencing on October 16, 2023, the Issuer may redeem, at its option, the Preferred Stock, in whole or in part, at a cash redemption price of $10.00 per share, plus all accrued and unpaid dividends to, but not including, the redemption date. Upon the occurrence of a Change of Control the Issuer is required to redeem any or all of the shares of Series A Convertible Preferred Stock at a redemption price of $11.00 per share, plus any accrued but unpaid dividends to, but excluding, the redemption date. Read SEC document |
| August 24, 2021 Filed Aug 25, 2021 14:15 UTC | cbdMD, Inc. YCBD · Entity 8230 | PurchaseCommon stock | 7,400 | $2.04 | $15,096.00 |
DisclosureSEC source: 0001654954-21-009413 · section16.xml · nonDerivative · entry 1 Kennedy Thomas Ronan · CIK 0001826452 · CFO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,400 Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 21:02 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock option · Derivative | 41,666 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0001654954-20-010735 · section16.xml · derivative · entry 12 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,666 Underlying: Common stock · 41,666 shares Expires 2028-10-01 F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement. Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 21:02 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock option · Derivative | 41,667 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0001654954-20-010735 · section16.xml · derivative · entry 11 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,667 Underlying: Common stock · 41,667 shares Expires 2027-10-01 F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement. Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 21:02 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock option · Derivative | 41,667 | $0.00 Strike: $6.50 | $0.00 |
DisclosureSEC source: 0001654954-20-010735 · section16.xml · derivative · entry 10 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,667 Underlying: Common stock · 41,667 shares Expires 2026-10-01 F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement. Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 21:02 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock option · Derivative | 41,666 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001654954-20-010735 · section16.xml · derivative · entry 9 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,666 Underlying: Common stock · 41,666 shares Expires 2028-10-01 F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement. Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 21:02 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock option · Derivative | 41,667 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001654954-20-010735 · section16.xml · derivative · entry 8 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,667 Underlying: Common stock · 41,667 shares Expires 2027-10-01 F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement. Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 21:02 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock option · Derivative | 41,667 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001654954-20-010735 · section16.xml · derivative · entry 7 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,667 Underlying: Common stock · 41,667 shares Expires 2026-10-01 F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement. Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 21:02 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock option · Derivative | 33,333 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001654954-20-010735 · section16.xml · derivative · entry 6 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Underlying: Common stock · 33,333 shares Expires 2028-10-01 F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement. Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 21:02 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock option · Derivative | 33,333 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001654954-20-010735 · section16.xml · derivative · entry 5 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Underlying: Common stock · 33,333 shares Expires 2027-10-01 F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement. Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 21:02 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantStock option · Derivative | 33,334 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001654954-20-010735 · section16.xml · derivative · entry 4 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,334 Underlying: Common stock · 33,334 shares Expires 2026-10-01 F4 · security: Represents stock option grant (the "Option") under the Plan pursuant to the terms of the Employment Agreement vesting and exercisable through the dates set forth provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement. Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 21:02 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantRestricted stock award · Derivative | 16,666 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-010735 · section16.xml · derivative · entry 3 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,666 Underlying: Common stock · 16,666 shares Expires 2023-10-01 F3 · security: RSA granted under the Plan pursuant to the terms of the Employment Agreement. Each RSA represents the right to receive one share of the Issuer's common stock on October 1, 2023 provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement. Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 21:02 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantRestricted stock award · Derivative | 16,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-010735 · section16.xml · derivative · entry 2 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Common stock · 16,667 shares Expires 2022-10-01 F2 · security: RSA granted under the Plan pursuant to the terms of the Employment Agreement. Each RSA represents the right to receive one share of the Issuer's common stock on October 1, 2022 provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement. Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 21:02 UTC | cbdMD, Inc. YCBD · Entity 8230 | GrantRestricted stock award · Derivative | 16,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-010735 · section16.xml · derivative · entry 1 Kennedy Thomas Ronan · CIK 0001826452 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Common stock · 16,667 shares Expires 2021-10-01 F1 · security: Restricted stock award ("RSA") granted under the Issuer's 2015 Equity Compensation Plan (the "Plan") pursuant to the terms of the Executive Employment Agreement dated September 15, 2020, with an effective date of October 1, 2020 (the "Employment Agreement") by and between the Issuer and the Reporting Person. Each RSA represents the right to receive one share of the Issuer's common stock on October 1, 2021 provided that the Reporting Person remains employed by the Issuer at that time, subject to acceleration as set forth in the Employment Agreement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.